The Democratic Republic of the Congo (DRC) has begun a clinical trial of an Ebola vaccine as part of efforts to contain the spread of the disease and strengthen its health response. The trial will evaluate the safety and efficacy of the vaccine, identify target groups and monitor any potential side e. .



